# Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients

> **NCT03557840** · NA · UNKNOWN · sponsor: **Paul M. Tulkens** · enrollment: 60 (estimated)

## Conditions studied

- Pharmacokinetics
- Antibacterial Agents
- Infections, Bacterial
- Infection
- Drug Monitoring
- Temocillin

## Interventions

- **DRUG:** temocillin

## Key facts

- **NCT ID:** NCT03557840
- **Lead sponsor:** Paul M. Tulkens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03557840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03557840, "Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03557840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*